EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
Burel-Vandenbos F, Benchetrit M, Miquel C, Fontaine D, Auvergne R, Lebrun-Frenay C, Cardot-Leccia N, Michiels JF, Paquis-Flucklinger V, Virolle T.
Burel-Vandenbos F, et al.
J Neurooncol. 2011 Apr;102(2):171-8. doi: 10.1007/s11060-010-0308-4. Epub 2010 Jul 24.
J Neurooncol. 2011.
PMID: 20652725